SSRI-induced indifference

Psychiatry (Edgemont)

Volumn 7, Issue 10, 2010, Pages 14-18

  Sansone, Randy A ^a   Sansone, Lori A ^b  

^a WRIGHT STATE UNIVERSITY   (United States)

^b WRIGHT PATTERSON AIR FORCE BASE   (United States)

Author keywords

Adverse effects; Apathy; Emotional blunting; Indifference; Selective serotonin reuptake inhibitor (SSRI); Side effects

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; FLUVOXAMINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADVERSE OUTCOME; ANXIETY DISORDER; APATHY; ARTICLE; ATTITUDE TO HEALTH; BEHAVIOR DISORDER; BLUNTED AFFECT; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMORBIDITY; DEPRESSION; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG MONITORING; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EMOTIONAL DISORDER; EMOTIONALITY; EMPIRICAL RESEARCH; HUMAN; MAJOR DEPRESSION; MENTAL HEALTH CARE; PATIENT EDUCATION; PRESCRIPTION; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL RATING SCALE; PSYCHOMETRY; RISK FACTOR; SEXUAL DYSFUNCTION; SIDE EFFECT; TREATMENT PLANNING;

EID: 78650057339     PISSN: 15505952     EISSN: 15555194     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Wikipedia. Selective serotonin reuptake inhibitor. http://en.wikipedia.org/wiki/Selective_serotonin_reuptake_inhibitor. Accessed 10/6/09.
2. Marin RS. Differential diagnosis and classification of apathy. Am J Psychiatry. 1990;147:22-30.
3. Reinblatt SP, Riddle MA. Selective serotonin reuptake inhibitorinduced apathy: a pediatric case series. J Child Adolesc Psychopharmacol. 2006;16:227-233.
4. Barnhart WJ, Makela EH, Latocha MJ. SSRI-induced apathy syndrome: a clinical review. J Psychiatric Pract. 2004;10:196-199.
5. Lee SI, Keltner NL. Antidepressant apathy syndrome. Perspect Psychiatr Care. 2005;41:188-192.
6. Opbroek A, Delgado PL, Laukes C, et al. Emotional blunting associated with SSRI-induced sexual dysfunction. Do SSRIs inhibit emotional responses? Int J Neuropsychopharmacol. 2002;5:147-151.
7. Price J, Goodwin GM. Emotional blunting or reduced reactivity following remission of major depression. Medicographia. 2009;31:152-156.
8. Price J, Cole V, Goodwin GM. Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study. Br J Psychiatry. 2009;195:211-217.
9. Bolling MY, Kohlenberg RJ. Reasons for quitting serotonin reuptake inhibitor therapy: paradoxical psychological side effects and patient satisfaction. Psychother Psychosom. 2004;73:380-385.
10. Fava M, Graves LM, Benazzi F, et al. A cross-sectional study of the prevalence of cognitive and physical symptoms during longterm antidepressant treatment. J Clin Psychiatry. 2006;67:1754-1759.
11. Wongpakaran N, van Reekum R, Wongpakaran T, Clarke D. Selective serotonin reuptake inhibitor use associates with apathy among depressed elderly: a case-controlled study. Ann Gen Psychiatry. 2007;6:7.
12. Garland EJ, Baerg EA. Amotivational syndrome associated with selective serotonin reuptake inhibitors in children and adolescents. J Child Adolesc Psychopharmacol. 2001;11:181-186.
13. Marin RS, Biedrzycki RC, Firinciogullari S. Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res. 1991;38:143-162.